S. Baker

发表

Nutritional anemia: its understanding and control with special reference to the work of the World Health Organization.

E. Demaeyer, S. J. Baker, S. Baker, 1979, The American journal of clinical nutrition.

An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site

Vincent Hernandez, Stephen J Benkovic, Lucy Shapiro, 2007, Science.

Therapeutic potential of boron-containing compounds.

Yi Xia, S. Baker, Yong-Kang Zhang, 2009, Future medicinal chemistry.

Unexpected formation of an epoxide-derived multisubstrate adduct inhibitor on the active site of GAR transformylase.

D. Boger, I. Wilson, S. Benkovic, 2001, Biochemistry.

Unexpected Formation of an Epoxide Derived Multisubstrate Adduct Inhibitor on the Active Site of GAR Transformylase

D. Boger, I. Wilson, S. Benkovic, 2001 .

Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutants.

R. Hamatake, Suoming Zhang, S. Baker, 2012, Journal of medicinal chemistry.

Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis.

K. R. Maples, S. Baker, Huchen Zhou, 2009, Bioorganic & medicinal chemistry letters.

Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors.

Yi Xia, S. Baker, M. Meewan, 2011, Bioorganic & medicinal chemistry letters.

Boron-containing inhibitors of synthetases.

S. Benkovic, S. Baker, J. Tomsho, 2011, Chemical Society reviews.

Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 protease.

Z. Ni, Suoming Zhang, S. Baker, 2010, Bioorganic & medicinal chemistry letters.

Design and synthesis of boron-containing PDE4 inhibitors using soft-drug strategy for potential dermatologic anti-inflammatory application.

S. Baker, J. Plattner, Yong-Kang Zhang, 2010, Bioorganic & medicinal chemistry letters.

Synthesis and evaluation of novel alpha-amino cyclic boronates as inhibitors of HCV NS3 protease.

Z. Ni, P. Rowland, S. Baker, 2010, Bioorganic & medicinal chemistry letters.

Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 protease.

Z. Ni, Suoming Zhang, S. Baker, 2010, Bioorganic & medicinal chemistry letters.

Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the potential treatment of onychomycosis.

S. Baker, Huchen Zhou, J. Plattner, 2006, Journal of medicinal chemistry.

Effect of ingesting fish oil on serum lipid and lipoprotein concentration in exercising and nonexercising women

S. Baker, R. Al‐Najadah, 1996 .

In Vitro penetration of a novel oxaborole antifungal (AN2690) into the human nail plate.

H. Maibach, S. Baker, R. Wester, 2007, Journal of pharmaceutical sciences.

Synthesis of two bi-functional ligands for the QUEST three-hybrid system

S. Benkovic, F. Salinas, S. Baker, 2000 .

Discovery of novel P3-oxo inhibitor of hepatitis C virus NS3/4A serine protease.

R. Hamatake, Suoming Zhang, S. Baker, 2012, Bioorganic & medicinal chemistry letters.

10-Formyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid (10-formyl-DDACTHF): a potent cytotoxic agent acting by selective inhibition of human GAR Tfase and the de novo purine biosynthetic pathway.

D. Boger, I. Wilson, S. Benkovic, 2002, Bioorganic & medicinal chemistry.

Parathyroid hormone, haematological and biochemical parameters in relation to dental disease and husbandry in rabbits.

S. Baker, F. Harcourt-Brown, 2001, The Journal of small animal practice.

Identification of borinic esters as inhibitors of bacterial cell growth and bacterial methyltransferases, CcrM and MenH.

L. Shapiro, S. Benkovic, P. Rajagopalan, 2005, Journal of medicinal chemistry.

Conformationally restricted analogues designed for selective inhibition of GAR Tfase versus thymidylate synthase or dihydrofolate reductase.

J. H. Shim, D. Boger, S. Benkovic, 2000, Bioorganic & medicinal chemistry.

Synthesis of [1-2H]- and [3-2H]-guanosine

S. Baker, D. W. Young, 2000 .

Synthesis of isotopically labelled (3-14C)-and (3,3-2H2)-5-fluoro-1,3-dihydro-1-hydroxy-2,1 -benzoxaborole (AN2690), a new antifungal agent for the potential treatment of onychomycosis

S. Baker, J. Plattner, Yong-Kang Zhang, 2007 .

Recent progress on the topical therapy of onychomycosis

S. Baker, K. Beutner, J. Plattner, 2007, Expert opinion on investigational drugs.

Progress on New Therapeuties for Fungal Nail Infections

H. Maibach, S. Baker, X. Hui, 2005 .

Subclinical intestinal malabsorption in developing countries.

S. Baker, 1976, Bulletin of the World Health Organization.

Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moieties.

Z. Ni, Suoming Zhang, S. Baker, 2011, Bioorganic & medicinal chemistry letters.

Design, synthesis, and biological evaluation of fluoronitrophenyl substituted folate analogues as potential inhibitors of GAR transformylase and AICAR transformylase.

J. H. Shim, D. Boger, S. Benkovic, 2000, Bioorganic & medicinal chemistry letters.

Identification of a novel boron-containing antibacterial agent (AN0128) with anti-inflammatory activity, for the potential treatment of cutaneous diseases.

S. Benkovic, K. R. Maples, Rajeshwar Singh, 2006, Bioorganic & medicinal chemistry letters.

Using an AraC-based three-hybrid system to detect biocatalysts in vivo

Stephen J Benkovic, S. Benkovic, F. Salinas, 2000, Nature Biotechnology.

Crystal structures of the human and fungal cytosolic Leucyl-tRNA synthetase editing domains: A structural basis for the rational design of antifungal benzoxaboroles.

Vincent Hernandez, S. Cusack, S. Baker, 2009, Journal of molecular biology.

Boron-Containing Inhibitors of Synthetases

S. Benkovic, S. Baker, J. Tomsho, 2011 .

Discovery of a Novel Class of Boron-Based Antibacterials with Activity against Gram-Negative Bacteria

J. Nieman, S. Cusack, D. Livermore, 2013, Antimicrobial Agents and Chemotherapy.

Novel macrocyclic HCV NS3 protease inhibitors derived from α-amino cyclic boronates.

William McDowell, Yang Liu, Dazhong Fan, 2010, Bioorganic & medicinal chemistry letters.

Synthesis of homochiral tetrahydropteridines

S. Baker, K. Beresford, D. W. Young, 2014 .

with Activity against Gram-negative Bacteria

J. Nieman, S. Cusack, D. Livermore, 2013 .